ArticlePloS one2019

Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study.

Su Jin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.